Sanuwave Health Free Cash Flow 2010-2024 | SNWV
Sanuwave Health Annual Free Cash Flow | |
---|---|
2023 | -4.52 |
2022 | -16.84 |
2021 | -6.94 |
2020 | -12.77 |
2019 | -6.47 |
2018 | -3.66 |
2017 | -1.53 |
2016 | -3.21 |
2015 | -3.37 |
2014 | -6.69 |
2013 | -3.92 |
2012 | -4.29 |
2011 | -8.87 |
2010 | -5.86 |
2009 | -6.27 |
Sanuwave Health Quarterly Free Cash Flow | |
---|---|
2024-09-30 | 1.46 |
2024-06-30 | 0.23 |
2024-03-31 | 0.99 |
2023-12-31 | -4.52 |
2023-09-30 | -3.41 |
2023-06-30 | -1.38 |
2023-03-31 | -0.39 |
2022-12-31 | -16.84 |
2022-09-30 | -12.15 |
2022-06-30 | -4.25 |
2022-03-31 | -2.77 |
2021-12-31 | -6.94 |
2021-09-30 | -6.95 |
2021-06-30 | -5.53 |
2021-03-31 | -3.45 |
2020-12-31 | -12.77 |
2020-09-30 | -9.82 |
2020-06-30 | -5.63 |
2020-03-31 | -2.65 |
2019-12-31 | -6.47 |
2019-09-30 | -4.71 |
2019-06-30 | -3.41 |
2019-03-31 | -1.31 |
2018-12-31 | -3.66 |
2018-09-30 | -2.30 |
2018-06-30 | -1.61 |
2018-03-31 | -1.86 |
2017-12-31 | -1.53 |
2017-09-30 | -0.95 |
2017-06-30 | -0.57 |
2017-03-31 | -0.12 |
2016-12-31 | -3.21 |
2016-09-30 | -2.72 |
2016-06-30 | -1.73 |
2016-03-31 | -1.01 |
2015-12-31 | -3.37 |
2015-09-30 | -2.91 |
2015-06-30 | -1.92 |
2015-03-31 | -1.08 |
2014-12-31 | -6.69 |
2014-09-30 | -5.55 |
2014-06-30 | -4.10 |
2014-03-31 | -2.12 |
2013-12-31 | -3.92 |
2013-09-30 | -3.37 |
2013-06-30 | -1.98 |
2013-03-31 | -1.04 |
2012-12-31 | -4.29 |
2012-09-30 | -3.55 |
2012-06-30 | -2.51 |
2012-03-31 | -1.49 |
2011-12-31 | -8.87 |
2011-09-30 | -7.03 |
2011-06-30 | -5.03 |
2011-03-31 | -2.02 |
2010-12-31 | -5.86 |
2010-09-30 | -4.13 |
2010-06-30 | -3.01 |
2010-03-31 | -1.72 |
2009-12-31 | -6.27 |
2009-09-30 | -4.51 |
2009-06-30 | -3.02 |
2009-03-31 | -1.54 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.233B | $0.020B |
SANUWAVE Health, Inc. is engaged in the development and commercialization of non-invasive, biological response-activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's product candidates include its proprietary PACE technology applicable in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions; and dermaPACE for treatment of the skin and subcutaneous soft tissue. The Company's products help in activating biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. SANUWAVE Health, Inc. is based in Alpharetta, USA. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $204.284B | 25.22 |
Stryker (SYK) | United States | $148.861B | 33.55 |
Boston Scientific (BSX) | United States | $147.840B | 42.50 |
EssilorLuxottica (ESLOY) | France | $120.398B | 0.00 |
Medtronic (MDT) | Ireland | $112.636B | 16.73 |
Lonza Group Ag (LZAGY) | Switzerland | $46.153B | 0.00 |
Haleon (HLN) | United Kingdom | $41.736B | 27.12 |
GE HealthCare Technologies (GEHC) | United States | $39.899B | 20.69 |
ResMed (RMD) | United States | $36.307B | 29.83 |
Terumo (TRUMY) | Japan | $28.860B | 40.76 |
Koninklijke Philips (PHG) | Netherlands | $24.692B | 18.90 |
Zimmer Biomet Holdings (ZBH) | United States | $21.842B | 13.91 |
Insulet (PODD) | United States | $19.563B | 77.90 |
Baxter (BAX) | United States | $16.252B | 10.57 |
Smith & Nephew SNATS (SNN) | United Kingdom | $11.030B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $10.094B | 34.30 |
BellRing Brands (BRBR) | United States | $9.817B | 39.50 |
Demant (WILYY) | Denmark | $8.735B | 0.00 |
Lantheus Holdings (LNTH) | United States | $6.632B | 15.41 |
ICU Medical (ICUI) | United States | $4.089B | 38.93 |
Prestige Consumer Healthcare (PBH) | United States | $3.823B | 19.01 |
Haemonetics (HAE) | United States | $3.684B | 17.98 |
Envista Holdings (NVST) | United States | $3.623B | 26.99 |
Perrigo (PRGO) | Ireland | $3.281B | 9.66 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
QuidelOrtho (QDEL) | United States | $2.992B | 19.25 |
GN Store Nord (GNNDY) | Denmark | $2.797B | 17.94 |
Neogen (NEOG) | United States | $2.592B | 29.88 |
LeMaitre Vascular (LMAT) | United States | $2.203B | 53.55 |
AtriCure (ATRC) | United States | $1.926B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $1.514B | 26.50 |
InMode (INMD) | Israel | $1.434B | 8.62 |
AdaptHealth (AHCO) | United States | $1.368B | 9.78 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.343B | 0.00 |
BioLife Solutions (BLFS) | United States | $1.274B | 0.00 |
Owens & Minor (OMI) | United States | $1.145B | 8.95 |
Curaleaf Holdings (CURLF) | Canada | $0.903B | 0.00 |
Evolus (EOLS) | United States | $0.895B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.881B | 15.54 |
CeriBell (CBLL) | United States | $0.833B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.678B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.572B | 25.24 |
Omeros (OMER) | United States | $0.538B | 0.00 |
Surmodics (SRDX) | United States | $0.530B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.434B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.418B | 0.00 |
ZimVie (ZIMV) | United States | $0.391B | 32.91 |
Quanterix (QTRX) | United States | $0.386B | 0.00 |
Valneva SE (VALN) | France | $0.376B | 0.00 |
Cerus (CERS) | United States | $0.336B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.330B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.317B | 30.11 |
Biote (BTMD) | United States | $0.307B | 6.73 |
OraSure Technologies (OSUR) | United States | $0.290B | 19.45 |
Canopy Growth (CGC) | Canada | $0.263B | 0.00 |
Zynex (ZYXI) | United States | $0.261B | 54.53 |
High Tide (HITI) | Canada | $0.244B | 100.33 |
Utah Medical Products (UTMD) | United States | $0.213B | 14.71 |
Aurora Cannabis (ACB) | Canada | $0.212B | 0.00 |
Brainsway (BWAY) | Israel | $0.208B | 110.50 |
Organigram Holdings (OGI) | Canada | $0.198B | 0.00 |
MacroGenics (MGNX) | United States | $0.193B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.153B | 0.00 |
Veru (VERU) | United States | $0.152B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.149B | 0.00 |
FitLife Brands (FTLF) | United States | $0.145B | 18.29 |
Jin Medical (ZJYL) | China | $0.136B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.127B | 0.00 |
Fonar (FONR) | United States | $0.097B | 11.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
InterCure (INCR) | Israel | $0.078B | 0.00 |
INLIF (INLF) | $0.074B | 0.00 | |
Exagen (XGN) | United States | $0.071B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.070B | 36.33 |
Apyx Medical (APYX) | United States | $0.057B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
ImmuCell (ICCC) | United States | $0.046B | 0.00 |
Modular Medical (MODD) | United States | $0.043B | 0.00 |
Safety Shot (SHOT) | United States | $0.029B | 0.00 |
Nephros (NEPH) | United States | $0.017B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.015B | 0.00 |
Flora Growth (FLGC) | United States | $0.013B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.008B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
Agape ATP (ATPC) | $0.006B | 0.00 | |
IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.003B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
United-Guardian (UG) | United States | $0.000B | 14.07 |
SNDL (SNDL) | Canada | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |